Skip to content

Pulmatrix, Inc.

PULM

CIK 0001574235 · Pharmaceutical Preparations · Nasdaq

  • Ruthigen, Inc. (until 2015-06-16)
← back to feed
Revenue (TTM)
$9.56M
+7.0% YoY FY Jun 2026
Net Income (TTM)
−$5.41M
+46.0% YoY FY Jun 2026
EPS Diluted (TTM)
−$1.48
+46.2% YoY FY Jun 2026
Gross Margin
—
FY Jun 2026
Operating Margin
-58.1%
FY Jun 2026
Net Margin
-56.6%
FY Jun 2026
Free Cash Flow (TTM)
−$10.8M
FY Jun 2026
Cash
$3.32M
FY Jun 2026
Total Debt
$1.8M
FY Jun 2026
Shares Outstanding
3.65M sh
FY Jun 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings